Nanocarriers containing platinum compounds for combination chemotherapy.

Area of Science:

• Oncology
• Nanotechnology
• Materials Science

Background:

• Platinum compounds are a cornerstone of cancer chemotherapy.
• Significant challenges include severe side effects and the development of drug resistance.
• Nanocarrier systems offer a promising strategy to enhance combination chemotherapy.

Purpose of the Study:

• To review recent advancements in nanocarrier-based platinum compounds for combination cancer therapy.
• To detail various nanocarrier platforms utilized for platinum drug delivery.
• To highlight the potential of these systems in overcoming treatment limitations.

Main Methods:

• Comprehensive literature review of nanocarrier systems for platinum-based chemotherapy.
• Detailed examination of diverse nanocarrier types: liposomes, polymer nanoparticles, micelles, silica nanoparticles, carbon nanohorns, nanobins, nanotubes, nanostructured lipid carriers, solid lipid nanoparticles, and fiber mats.
• Analysis of combination chemotherapy strategies using platinum compounds within nanocarriers.

Main Results:

• Various nanocarrier platforms demonstrate potential for improved platinum drug delivery.
• Combination chemotherapy using nanocarriers can mitigate side effects and overcome resistance.
• Specific nanocarrier types show promise for targeted delivery and enhanced therapeutic efficacy.

Conclusions:

• Nanocarrier-based platinum compounds represent a significant advancement in cancer treatment.
• These systems offer a viable strategy to address the limitations of conventional platinum chemotherapy.
• Further research into specific nanocarrier designs is crucial for clinical translation.